169177 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum Mitochondria
SYSTEM AND METHOD FOR PREDICTIVE MODELING OF CELLULAR SYSTEMS
#2METHODS FOR MITOCHONDRIAL pH PROBES
#3IMMUNE HEALTH IMPROVERS
#4COMPOSITIONS AND METHODS FOR THE MODULATION OF MITOPHAGY FOR USE IN TREATMENT OF MITOCHONDRIAL DISEASE
#5COMPOSITIONS AND METHODS THAT PROMOTE HYPOXIA OR THE HYPOXIA RESPONSE FOR TREATMENT AND PREVENTION OF MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS DISORDERS
#6GENETICALLY-ENCODED VOLTAGE SENSOR FOR THE MITOCHONDRIAL INNER MEMBRANE
#7Automated Isolation of Viable Mitochondria
#8Bioactive mitochondria encapsulated in a metal organic framework
#9AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#10SCREENING FOR PHARMACEUTICAL COMPOUNDS FOR IMPROVING MITOCHONDRIAL FUNCTION
#11GLIOMA THERAPY
#12PH-ACTIVABLE FLUORESCENT PROBES FOR TARGETING CELL ORGANELLES
#13COMPOSITIONS AND METHODS OF USING THE SAME FOR TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE
#14ENHANCED MITOCHONDRIAL RESPONSE WITH THIOZOLIDINEDIONE, PIOGLITAZONE OR ROSIGLITAZONE
#15METHODS OF TREATING CANCER
#16MITOTHERAPEUTICS FOR THE TREATMENT OF BRAIN DISORDERS
#17NDUFS2 SUBUNIT KNOCKOUT HUMAN CELL LINE
#18Compositions and methods for regulating glucose homeostasis and insulin action
#19COMPOSITIONS AND METHODS FOR ASSESSING TOXICITY USING DYNAMIC BH3 PROFILING
#20Automated isolation of viable mitochondria
#21AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#22COMPOSITIONS AND METHODS THAT PROMOTE HYPOXIA OR THE HYPOXIA RESPONSE FOR TREATMENT AND PREVENTION OF MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS DISORDERS
#23PREDICTING RESPONSE TO ALVOCIDIB BY MITOCHONDRIAL PROFILING
#24High throughput BH3 profiling: a rapid and scalable technology to BH3 profile on low numbers of cells
#25Methods of BH3 profiling
#26Compositions and methods for regulating glucose homeostasis and insulin action
#27METHOD FOR SCREENING COMPOUNDS THAT MODULATE THE ACTIVITY OF THE ELECTRON TRANSPORT CHAIN
#28Mitoflavoscins: targeting flavin-containing enzymes eliminates cancer stem cells (CSCS) by inhibiting mitochondrial respiration
#29PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
#30Dynamic BH3 profiling
#31Diagnostics Platform for Mitochondrial Dysfunctions/Diseases
#32BIOENERGETIC PROFILING OF CIRCULATING BLOOD CELLS AND SYSTEMS, DEVICES, AND METHODS RELATING THERETO
#33Compositions and methods of regulating glucose homeostasis and insulin action
#34Predicting response to alvocidib by mitochondrial profiling
#35METHOD FOR DELIVERING EXOGENOUS MITOCHONDRIA INTO CELLS
#36DIFFERENTIAL BH3 MITOCHONDRIAL PROFILING
#37Profiling peptides and methods for sensitivity profiling
#38Mitochondria-targeting fluorescent potassium+ sensor and method of making the same
#39System and method for quantitatively mapping mitochondrial membrane potential
#40AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#413-D TISSUE CULTURE BASED METHOD TO ASSESS MITOCHONDRIAL IMPAIRMENT
#42PH responsive fluorescent compound, composition for detecting mitophagy using same, and method for detecting mitophagy within cells
#43Predicting response to alvocidib by mitochondrial profiling
#44Compositions and methods that promote hypoxia or the hypoxia response for treatment and prevention of mitochondrial dysfunction and oxidative stress disorders
#45Profiling peptides and methods for sensitivity profiling
#46Treatment for mitochondrial diseases
#47Methods and compositions useful for treating diseases involving Bcl-2 family proteins with quinoline derivatives
#48Modulators of mitochondrial protein import
#49BIOENERGETIC PROFILING OF CIRCULATING BLOOD CELLS AND SYSTEMS, DEVICES, AND METHODS RELATING THERETO
#50IDENTIFICATION OF FACTORS FOR THE TREATMENT OF MITOCHONDRIAL AND AGE-RELATED DISEASES
#51Profiling peptides and methods for sensitivity profiling
#52High throughput BH3 profiling: a rapid and scalable technology to BH3 profile on low numbers of cells
#53Mitochondrial apoptotic sensor
#54Mitochondrial epigenetic reprogramming and transplant
#55SAB as a biomarker for degenerative diseases and therapeutic sensitivity in cancers
#56Peptide regulators of mitochondrial fusion and methods of use
#57BIOMARKER FOR PARKINSON'S DISEASE AND USE THEREOF
#58Method for selecting patients responsive for cancer treatments
#59BIOMARKER FOR DETERMINING MITOCHONDRIAL DAMAGE IN FRIEDREICH'S ATAXIA
#60Method for screening activator of mitochondrial activity
#61Compositions and methods for regulating glucose homeostasis and insulin action
#62Mitochondrial preproteins as markers for Alzheimer's disease
#63Methods of modulating WARS2
#64Biomarker for parkinson's disease and use thereof
#65Methods and Compositions for Inhibiting Mitochondrial Trafficking
#66AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#67Predicting response to alvocidib by mitochondrial profiling
#68Methods, compositions and kits for assaying mitochondrial function
#69Extracellular mitochondrial components for detecting inflammatory reactions and conditions
#70Methods of BH3 profiling
#71METHOD OF SCREENING FOR COMPOUNDS USEFUL IN THE TREATMENT OF HUNTINGTON DISEASE
#72METHOD OF SCREENING FOR COMPOUNDS USEFUL IN THE TREATMENT OF ALZHEIMER DISEASE
#73Genetically encoded probe for quantification of pyruvate concentration and methods of using the same
#74DIFFERENTIAL BH3 MITOCHONDRIAL PROFILING
#75Dynamic BH3 profiling
#76Compositions and methods for regulating glucose homeostasis and insulin action
#77Method and system for continous monitoring of toxicity
#78Multifunctional radical quenchers for the treatment of mitochondrial dysfunction
#79MITOCHONDRIAL TOXICITY TEST
#80Methods, compositions and kits for assaying mitochondrial function
#81METHOD USING FLUORESCENT TURN-ON PROBES FOR CELL-SPECIFIC DETECTION
#82METHOD OF IDENTIFYING AND SCREENING DRUG CANDIDATE FOR PREVENTING AND/OR TREATING ISCHEMIC MYOCARDIAL DISEASE
#83METHODS AND COMPOSITIONS USEFUL FOR TREATING DISEASES INVOLVING BCL-2 FAMILY PROTEINS WITH QUINOLINE DERIVATIVES
#84METHODS AND COMPOSITIONS USEFUL FOR TREATING DISEASES INVOLVING BCL-2 FAMILY PROTEINS WITH QUINOLINE DERIVATIVES
#85Biomarker for determining mitochondrial damage in friedreich's ataxia
#86Mitochondrial ribosomal proteins as aging regulators
#87Variable color two-photon fluorescent probe, method for imaging thiol activation in mitochondrion using same, and method for manufacturing the variable color two-photon fluorescent probe
#88Induction of the mitochondrial permeability transition
#89Multifunctional radical quenchers for the treatment of mitochondrial dysfunction
#90ANIMAL MODEL HAVING PHOTO-ACTIVATABLE MITOCHONDRIA
#91In vitro mitochondrial function test (MFT) and uses thereof
#92INDUCED DENDRITIC CELL COMPOSITIONS AND USES THEREOF
#93METHODS, COMPOSITIONS AND KITS FOR ASSAYING MITOCHONDRIAL FUNCTION
#94AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#95METHODS, COMPOSITIONS AND KITS FOR ASSAYING MITOCHONDRIAL FUNCTION
#96COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF MITOCHONDRIAL DISEASES
#97Pharmaceutical substances on the basis of mitochondria-addressed antioxidants
#98MITOCHONDRIAL FUNCTION OF PROHIBITIN 2 (PHB2)
#99Mitochondrial function of prohibitin 2 (PHB2)
#100Anti-aging agents and methods to identify them
#101MITOCHONDRIAL INHIBITORS AND USES THEREOF
#102DIAGNOSTIC AND THERAPEUTIC TREATMENTS RELATED TO MITOCHONDRIAL DISORDERS
#103Isolation and characterization of a single mitochondrion
#104Kit for positively detecting toxic material
#105METHODS FOR IDENTIFYING MODULATORS OF APOPTOSIS
#106Methods and devices for assessment of mitochondrial function
#107Categorically ranking animals for feed efficiency
#108Assay system to identify therapeutic agents
#109NOVEL MITOCHONDRIAL DYE
#110Assays for mutagenesis detection
#111Pro-oxidant anti-cancer compounds
#112Method to predict toxicity using the analysis of dynamic organelle behaviour
#113Methods and compositions for modulating BCL-2 family polypeptides
#114METHOD AND SYSTEM FOR MEASURING MEMBRANE POTENTIAL BASED ON FLUORESCENCE POLARIZATION
#115Anti aging agents and methods to identify them
#116METHOD FOR MEASURING MITOCHONDRIAL MEMBRANE POTENTIAL IN VERTEBRATE CELLS
#117Altered Mitochondrial Activity in Diseases Resulting From Oxidative Stress
#118GENES INVOLVED IN MITOCHONDRIAL BIOGENESIS
#119Jasmonate based assays for identifying compounds that selectively inhibit mitochondrial bound hexokinases
#120Mitochondrial function of prohibitin 2 (PHB2)
#121Cytochrome c acetylation
#122Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#123Conversion of apoptotic proteins
#124Methods and kits for diagnosis of schizophrenia
#125Methods for identifying modulators of apoptosis
#126METHODS FOR DRUG DISCOVERY, DISEASE TREATMENT, AND DIAGNOSIS USING METABOLOMICS
#127Method for Screening Substance by Measuring PPAR DELTA Activating Effect and Agent
#128ISOLATION AND CHARACTERIZATION OF A SINGLE MITOCHONDRION
#129RNA-selective probes for live cell imaging of nuclear structure and function
#130Diagnostic and Therapeutic Treatments Related to Mitochondrial Disorders
#131Methods of Validating Target for Modulating Insulin Action, Screening for Modulators of Insulin Action and Therapeutic Uses Thereof
#132Method for positively detecting toxic material
#133Method and system for measuring membrane potential based on fluorescence polarization
#134Mitoquinone derivatives used as mitochondrially targeted antioxidants
#135Method for detecting the effect of a toxic substance using sub-mitochondrial particle
#136Methods Of Regulating Metabolism And Mitochondrial Function
#137Method of assaying substance capable of changing mitochondrial membrane potential
#138Categorically ranking animals for feed efficiency
#139Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#140Methods of identifying agents that modulate mitochondrial function
#141Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#142Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#143Method for detecting presence of toxic material within sample
#144Conversion of apoptotic proteins
#145Induction of apoptosis by cellular stress
#146F-18-fluorinated phosphonium cation imaging agents and methods of synthesis
#147Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#148Conversion of apoptotic proteins
#149Induction of the mitochondrial permeability transition
#150AKAP84 and its use for visualization of biological structures
#151Methods for drug discovery disease treatment, and diagnosis using metabolomics
#152Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#153Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#154Microarrays of functional biomolecules, and uses therefor
#155Microarrays of functional biomolecules, and uses therefor
#156Microarrays of functional biomolecules, and uses therefor
#157Peripheral benzodiazepine receptor independent superoxide generation
#158Methods and compositions for regulation and manipulation of steroidogenesis
#159Screening methods for the identification of inhibitors of human immunodeficiency virus (HIV) viral protein R (Vpr) binding to the adenine nucleotide translocator (ANT)
#160Cytochrome c acetylation
#161Screening assays using intramitochondrial calcium
#162Modulation of apoptosis
#163Method and apparatus for high density format screening for bioactive molecules
#164Assay for detecting changes in mitochondrial membrane permeability and method of using same
#165Methods for drug discovery, disease treatment, and diagnosis using metabolomics